Long‐term risk of venous thromboembolism among patients with gastrointestinal non‐neoplastic and neoplastic diseases: A prospective cohort study of 484 211 individuals
American Journal of Hematology · 2024
DOI: 10.1002/ajh.27106 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Shuai Yuan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Big Data in Health Science School of Public Health, Center of Clinical Big Data and Analytics of The Second Affiliated Hospital, Zhejia…. Hauptthemen laut MEDLINE: Venous Thromboembolism, Crohn Disease, Gastrointestinal Neoplasms, Pancreatitis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Forskningsrådet om Hälsa, Arbetsliv och Välfärd, Hjärt-Lungfonden, Karolinska Institutet.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
We conducted a prospective cohort study to examine the associations of 21 gastrointestinal diseases with the risk of incident venous thromboembolism (VTE). The study included 485 936 UK Biobank participants free of baseline VTE. The gastrointestinal diseases were defined by the International Classification of Disease (ICD)‐9 and 10 codes with data from the nationwide inpatient data set, the primary care data set, and the cancer registries. Incident VTE cases were defined by ICD‐9 and 10 codes with data from the nationwide inpatient data set. Cox proportional hazards regression was used to estimate the associations of baseline gastrointestinal diseases with incident VTE risk. During a median follow‐up of 12.0 years, 13 646 incident VTE cases were diagnosed. Eleven gastrointestinal diseases (nine non‐neoplastic and two neoplastic) were associated with an increased risk of incident VTE after Bonferroni corrections. The risk of VTE was >50% higher among patients with gallbladder and biliary tract cancer (hazard ratio [HR] 3.15, 95% confidence interval [CI] 95% CI 1.74–5.70), pancreatic cancer (HR 2.84, 95% CI 1.65–4.91), cirrhosis (HR 2.34, 95% CI 1.96–2.79), Crohn's disease (HR 1.61, 95% CI 1.33–1.95), or pancreatitis (HR 1.57, 95% CI 1.31–1.88) compared with individuals without each of these diseases. We observed multiplicative interactions of age, sex, and body mass index with some gastrointestinal diseases ( p < .05). A more pronounced, increased risk of VTE was found among younger, female, or obese patients. The study suggests a 50% higher risk of developing VTE among patients with gallbladder and biliary tract cancer, pancreatic cancer, cirrhosis, Crohn's disease, or pancreatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Big Data in Health Science School of Public Health, Center of Clinical Big Data and Analytics of The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
- Unit of Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
ORCID-Profile: Shuai Yuan, Xue Li, Susanna C Larsson
Förderung
- Forskningsrådet om Hälsa, Arbetsliv och Välfärd
- Hjärt-Lungfonden
- Karolinska Institutet
- Vetenskapsrådet
Zitieren
APA
Yuan, S., Sun, Y., Chen, J., Li, X., & Larsson, S. C. (2024). Long‐term risk of venous thromboembolism among patients with gastrointestinal non‐neoplastic and neoplastic diseases: A prospective cohort study of 484 211 individuals. American Journal of Hematology. https://doi.org/10.1002/ajh.27106
Vancouver
Yuan S, Sun Y, Chen J, Li X, Larsson SC. Long‐term risk of venous thromboembolism among patients with gastrointestinal non‐neoplastic and neoplastic diseases: A prospective cohort study of 484 211 individuals. American Journal of Hematology. 2024. doi:10.1002/ajh.27106
BibTeX
@article{Yuan2024,
author = {Yuan, Shuai and Sun, Yuhao and Chen, Jie and Li, Xue and Larsson, Susanna C},
title = {Long‐term risk of venous thromboembolism among patients with gastrointestinal non‐neoplastic and neoplastic diseases: A prospective cohort study of 484 211 individuals},
journal = {American Journal of Hematology},
year = {2024},
doi = {10.1002/ajh.27106}
}
EUVIMED